PLATINUM for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where PLATINUM was used for Diffuse large b-cell lymphoma refractory.
Most Reported Side Effects for PLATINUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 43 | 13.1% | 5 | 9 |
| Off label use | 29 | 8.8% | 3 | 13 |
| Fatigue | 27 | 8.2% | 6 | 9 |
| Metabolic disorder | 24 | 7.3% | 0 | 0 |
| Thrombocytopenia | 24 | 7.3% | 1 | 4 |
| Pneumonitis | 23 | 7.0% | 4 | 6 |
| Anaemia | 22 | 6.7% | 2 | 4 |
| Malignant neoplasm progression | 22 | 6.7% | 7 | 6 |
| Neutropenia | 22 | 6.7% | 1 | 1 |
| Blood lactate dehydrogenase increased | 20 | 6.1% | 0 | 0 |
| Hepatitis b core antibody positive | 15 | 4.6% | 0 | 0 |
| Diarrhoea | 14 | 4.3% | 4 | 4 |
| Nausea | 14 | 4.3% | 1 | 1 |
| Vomiting | 14 | 4.3% | 4 | 5 |
| Acute kidney injury | 13 | 4.0% | 1 | 4 |
Other Indications for PLATINUM
Non-small cell lung cancer (58)
Product used for unknown indication (41)
Non-small cell lung cancer metastatic (18)
Plasma cell myeloma (18)
Osteosarcoma (15)
Lung adenocarcinoma (14)
Small cell lung cancer (11)
Lymphoma transformation (9)
Non-hodgkin's lymphoma (9)
Plasma cell leukaemia (7)
Other Drugs Used for Diffuse large b-cell lymphoma refractory
RITUXIMAB (667)
EPCORITAMAB-BYSP (353)
AXICABTAGENE CILOLEUCEL (336)
BENDAMUSTINE (283)
CYCLOPHOSPHAMIDE (226)
POLATUZUMAB VEDOTIN (223)
ETOPOSIDE (165)
POLATUZUMAB VEDOTIN-PIIQ (158)
GEMCITABINE (147)
LENALIDOMIDE (143)